ZLDI-8, CAS [[667880-38-8]]

Produktübersicht

• Artikelname: ZLDI-8, CAS [[667880-38-8]]
• Artikelnummer: MCE-HY-123931
• Hersteller Artikelnummer: HY-123931
• Alternativnummer: MCE-HY-123931-50MG,MCE-HY-123931-100MG,MCE-HY-123931-25MG,MCE-HY-123931-10MMX1ML,MCE-HY-123931-5MG,MCE-HY-123931-10MG
• Hersteller: MedchemExpress
• Kategorie: Biochemikalien

Produktbeschreibung

ZLDI-8 is a Notch activating/cleaving enzyme ADAM-17 inhibitor and inhibits the cleavage of Notch protein. ZLDI-8 decreases the expression of pro-survival/anti-apoptosis and epithelial-mesenchymal transition (EMT) related proteins. ZLDI-8 is also a competitive and irreversible tyrosine phosphatase (Lyp) inhibitor with an IC50 of 31.6 µM and a Ki of 26.22 µM. ZLDI-8 inhibits the growth of MHCC97-H cells with an IC50 of 5.32 µM[1][2].

Produkteigenschaften

• Molekulargewicht: 433.52
• Reinheit: 98.47
• CAS Nummer: [667880-38-8]
• Formel: C24H23N3O3S
• Target-Kategorie: Apoptosis,Notch,Phosphatase

Anwendungsbeschreibung

• Anwendungsbeschreibung: Reference compound